SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Caliway Biopharmaceuticals Co., Ltd. (6919.TW) News

Track canonical SquawkNews coverage tagged to 6919.TW, Caliway Biopharmaceuticals Co., Ltd.. This hub brings together deduplicated headlines about taiwan, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 6919.TW Asset equity Sector Markets 90 days 1 Last 83.1 Updated Sep 21, 2026, 10:18 AM UTC Open live news feed
M Caliway Pharma drug Cbl-514 shows statistically significant efficacy in Phase II trial CALIWAY BIOPHARMACEUTICALS CO., LTD. announced on Sept. 21 that its new drug Cbl-514 demonstrated statistically significant efficacy in its Phase II clinical trial, meeting the primary efficacy endpoint. EQUITY | Sep 21, 2026, 10:18 AM UTC